T‐cell signature cytokines distinguish pulmonary sarcoidosis from pulmonary tuberculosis

Abstract

AbstractSarcoidosis is a systemic inflammatory disorder characterized by tissue infiltration due to mononuclear phagocytes and lymphocytes and associated noncaseating granuloma formation. Pulmonary sarcoidosis (PS) shares a number of clinical, radiological, and histopathological characteristics with that of pulmonary tuberculosis (PTB). Due to this, clinicians face issues in differentiating between PS and PTB in a substantial number of cases. There is a lack of any specific biomarker that can diagnose PS distinctively from PTB. We compared T‐cell‐based signature cytokines in patients with PS and PTB. In this study, we proposed a serum biomarker panel consisting of cytokines from cells: T helper (Th) 1 [interferon‐gamma (IFN‐γ); tumor necrosis factor‐alpha (TNF‐α)], Th9 [interleukin (IL)‐9], Th17 [IL‐17], and T regulatory (Treg) [IL‐10; transforming growth factor‐beta (TGF‐β)]. We performed the principal component analysis that demonstrated that our serum cytokine panel has a significant predictive ability to differentiate PS from PTB. Our results could aid clinicians to improve the diagnostic workflow for patients with PS in TB endemic settings where the diagnosis between PS and PTB is often ambiguous.